Inventor · disambiguated record
Kenneth D. Wild, Jr.
Also filed as: WILD JR KENNETH D · WILD KENNETH D
6 granted patents·4 pending applications·209 citations·filing 2004–2016
87Inventor score
Technology areasA61P
Top patents by PatentIndex Score
10 records- 0196US7795413B2Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsAMGEN INC·Filed 2007·Granted Sep 14, 2010·55 cites·9 claims
- 0295US8106167B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsWILD JR KENNETH D·Filed 2010·Granted Jan 31, 2012·54 cites·8 claims
- 0394US7601818B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsAMGEN INC·Filed 2004·Granted Oct 13, 2009·72 cites·26 claims
- 0491US8198410B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsWILD JR KENNETH D·Filed 2008·Granted Jun 12, 2012·19 cites·12 claims
- 0586US8513396B2Peptides and related molecules that modulate nerve growth factor activityBOONE THOMAS C·Filed 2012·Granted Aug 20, 2013·9 cites·6 claims
- 0659US2016304596A1Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitorsAMGEN INC·Filed 2016·Application pending·0 cites
- 0758US2013316448A1Peptides and related molecules that modulate nerve growth factor activityAMGEN INC·Filed 2013·Application pending·0 cites
- 0858US2016237147A1Human Anti-NGF Neutralizing Antibodies As Selective NGF Pathway InhibitorsAMGEN INC·Filed 2016·Application pending·0 cites
- 0955US2011091476A1Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway InhibitorsAMGEN INC·Filed 2010·Application pending·0 cites
- 1052US9260514B2Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsWILD JR KENNETH D·Filed 2009·Granted Feb 16, 2016·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Kenneth D. Wild, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →